Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pilot study of A-FABP levels as a predictive factor of SPECT results in asymptomatic relatives of patients with cardiovascular disease

E. Sovová, J. Vrbková, D. Stejskal, M. Kamínek, I. Metelková, M. Budikova, M. Kaletová, M. Sova, M. Sovová,

. 2014 ; 8 (5) : 633-40.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031909
E-zdroje Online Plný text

NLK ProQuest Central od 2007-06-01 do 2021-01-31
Health & Medicine (ProQuest) od 2007-06-01 do 2021-01-31
Public Health Database (ProQuest) od 2007-06-01 do 2021-01-31

BACKGROUND: A-FABP is a promising link between metabolic syndrome and atherosclerosis. It is not well known whether level of A-FABP predicts results of SPECT. PATIENTS & METHODS: In 82 subjects (53 males) with a median age of 54 years, who were first-degree relatives of patients with cardiovascular disease, the following tests and examinations were performed: A-FABP, calcium score (CS) and SPECT. RESULTS: Subjects with positive and negative SPECT results differed significantly in the noncategorized CS (p = 0.001), uric acid (p = 0.025) and the total cholesterol:high-density lipoprotein ratio (p = 0.043), but not in other parameters (including A-FABP). To predict SPECT results, the best model proved to be a logistic regression model with gender and noncategorized CS as predictors, with an area under the receiver operating characteristic curve of 0.89 (the sensitivity and specificity based on a CS cutoff of 11.1 were 77.78 and 75.34%, respectively). CONCLUSION: The serum level of A-FABP is not a predictor of a positive SPECT result.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031909
003      
CZ-PrNML
005      
20180514142253.0
007      
ta
008      
151005s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.2217/bmm.13.160 $2 doi
035    __
$a (PubMed)25123032
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Sovová, E $u Department of Internal Medicine I - Cardiology, Faculty of Medicine & Dentistry, Palacký University Olomouc & University Hospital Olomouc, Olomouc, Czech Republic.
245    10
$a Pilot study of A-FABP levels as a predictive factor of SPECT results in asymptomatic relatives of patients with cardiovascular disease / $c E. Sovová, J. Vrbková, D. Stejskal, M. Kamínek, I. Metelková, M. Budikova, M. Kaletová, M. Sova, M. Sovová,
520    9_
$a BACKGROUND: A-FABP is a promising link between metabolic syndrome and atherosclerosis. It is not well known whether level of A-FABP predicts results of SPECT. PATIENTS & METHODS: In 82 subjects (53 males) with a median age of 54 years, who were first-degree relatives of patients with cardiovascular disease, the following tests and examinations were performed: A-FABP, calcium score (CS) and SPECT. RESULTS: Subjects with positive and negative SPECT results differed significantly in the noncategorized CS (p = 0.001), uric acid (p = 0.025) and the total cholesterol:high-density lipoprotein ratio (p = 0.043), but not in other parameters (including A-FABP). To predict SPECT results, the best model proved to be a logistic regression model with gender and noncategorized CS as predictors, with an area under the receiver operating characteristic curve of 0.89 (the sensitivity and specificity based on a CS cutoff of 11.1 were 77.78 and 75.34%, respectively). CONCLUSION: The serum level of A-FABP is not a predictor of a positive SPECT result.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    12
$a asymptomatické nemoci $7 D058070
650    _2
$a vápník $x krev $7 D002118
650    12
$a kardiovaskulární nemoci $7 D002318
650    _2
$a proteiny vázající mastné kyseliny $x krev $7 D050556
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a rodokmen $7 D010375
650    _2
$a pilotní projekty $7 D010865
650    12
$a jednofotonová emisní výpočetní tomografie $7 D015899
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vrbková, J
700    1_
$a Stejskal, D
700    1_
$a Kamínek, M
700    1_
$a Metelková, I
700    1_
$a Budikova, M
700    1_
$a Kaletová, M
700    1_
$a Sova, M
700    1_
$a Sovová, Markéta $7 xx0224226
773    0_
$w MED00172897 $t Biomarkers in medicine $x 1752-0371 $g Roč. 8, č. 5 (2014), s. 633-40
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25123032 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20180514142426 $b ABA008
999    __
$a ok $b bmc $g 1092785 $s 915035
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 8 $c 5 $d 633-40 $i 1752-0371 $m Biomarkers in medicine $n Biomark Med $x MED00172897
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...